Literature DB >> 1738200

Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression.

B Dropulić1, N H Lin, M A Martin, K T Jeang.   

Abstract

We have designed a ribozyme that cleaves human immunodeficiency virus type 1 (HIV-1) RNA in U5 (at nucleotide +115). This ribozyme was tested in vitro and was found to give efficient and specific digestion of RNA containing the HIV-1 U5 sequence. When the U5 ribozyme was placed into the HIV-1 genome, virus replication was suppressed in tissue culture. Introduction of this ribozyme into cells by using an amphotropic retrovirus vector significantly reduced expression of U5-containing RNA in cells chronically infected with HIV-1. Naive T cells were cocultivated with packaging cells that produce defective amphotropic retroviruses containing the U5 ribozyme. These lymphocytes were found to be partially protected from HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738200      PMCID: PMC240867     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  Can ribozymes be used to regulate procaryote gene expression?

Authors:  J C Chuat; F Galibert
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

3.  Autolytic processing of dimeric plant virus satellite RNA.

Authors:  G A Prody; J T Bakos; J M Buzayan; I R Schneider; G Bruening
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

4.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

5.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells.

Authors:  P H Correll; Y Kew; L K Perry; R O Brady; J K Fink; S Karlsson
Journal:  Hum Gene Ther       Date:  1990       Impact factor: 5.695

8.  Specific gene suppression by engineered ribozymes in monkey cells.

Authors:  F H Cameron; P A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA.

Authors:  G Sczakiel; M Pawlita
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  37 in total

1.  Inhibition of hepatitis B virus X gene expression by novel DNA enzymes.

Authors:  R Goila; A C Banerjea
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Ribozymes that cleave reovirus genome segment S1 also protect cells from pathogenesis caused by reovirus infection.

Authors:  S Shahi; G K Shanmugasundaram; A C Banerjea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Expression of lexA targeted ribozyme in Escherichia coli BL-21 (DE3) cells.

Authors:  Ramesh Singh Yadava; Ravindra Kumar; Pramod Kumar Yadava
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

5.  Can hammerhead ribozymes be efficient tools to inactivate gene function?

Authors:  E Bertrand; R Pictet; T Grange
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

Review 6.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 7.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

8.  Effective ribozyme delivery in plant cells.

Authors:  R Perriman; G Bruening; E S Dennis; W J Peacock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.

Authors:  R B Denman; M Smedman; W Ju; R Rubenstein; A Potempska; D L Miller
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

10.  A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1.

Authors:  M Yu; J Ojwang; O Yamada; A Hampel; J Rapapport; D Looney; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.